The association of TGF-β-enriched EVs with higher immunosuppression was so robust that the suppression of TGF-β expression in cancer cells was used as a strategy to increase the efficacy of tumor exosome-based vaccines[129]. This evidence concerns the gene TGFB1 and cancer.